Chemotherapy after progression on nivolumab is essential for responders with genetic alterations of driver gene: Review of two recurrent/metastatic oral squamous cell carcinoma patients.
Oral Oncol
; 102: 104509, 2020 03.
Article
in En
| MEDLINE
| ID: mdl-31839407
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Mouth Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Squamous Cell Carcinoma of Head and Neck
/
Neoplasm Recurrence, Local
Type of study:
Prognostic_studies
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Oral Oncol
Journal subject:
NEOPLASIAS
Year:
2020
Document type:
Article
Country of publication: